Skip to main content

Main menu

  • Home
  • Content
    • Published Ahead of Print
    • Current Issue
    • Podcasts
    • Subject Collections
    • Archives
    • Kidney Week Abstracts
    • Saved Searches
  • Authors
    • Submit a Manuscript
    • Author Resources
  • Trainees
    • Peer Review Program
    • Prize Competition
  • About CJASN
    • About CJASN
    • Editorial Team
    • CJASN Impact
    • CJASN Recognitions
  • More
    • Alerts
    • Advertising
    • Feedback
    • Reprint Information
    • Subscriptions
  • ASN Kidney News
  • Other
    • ASN Publications
    • JASN
    • Kidney360
    • Kidney News Online
    • American Society of Nephrology

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
American Society of Nephrology
  • Other
    • ASN Publications
    • JASN
    • Kidney360
    • Kidney News Online
    • American Society of Nephrology
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Advertisement
American Society of Nephrology

Advanced Search

  • Home
  • Content
    • Published Ahead of Print
    • Current Issue
    • Podcasts
    • Subject Collections
    • Archives
    • Kidney Week Abstracts
    • Saved Searches
  • Authors
    • Submit a Manuscript
    • Author Resources
  • Trainees
    • Peer Review Program
    • Prize Competition
  • About CJASN
    • About CJASN
    • Editorial Team
    • CJASN Impact
    • CJASN Recognitions
  • More
    • Alerts
    • Advertising
    • Feedback
    • Reprint Information
    • Subscriptions
  • ASN Kidney News
  • Visit ASN on Facebook
  • Follow CJASN on Twitter
  • CJASN RSS
  • Community Forum

More articles from Cystic Kidney Disease

  • Health Disparities in Autosomal Dominant Polycystic Kidney Disease (ADPKD) in the United States
    You have accessRestricted Access
    Health Disparities in Autosomal Dominant Polycystic Kidney Disease (ADPKD) in the United States
    Rita L. McGill, Milda R. Saunders, Alexandra L. Hayward and Arlene B. Chapman
    CJASN June 2022, CJN.00840122; DOI: https://doi.org/10.2215/CJN.00840122
    Add to Selected Citations
  • Total Kidney Volume Measurements in ADPKD by 3D and Ellipsoid Ultrasound in Comparison with Magnetic Resonance Imaging
    You have accessRestricted Access
    Total Kidney Volume Measurements in ADPKD by 3D and Ellipsoid Ultrasound in Comparison with Magnetic Resonance Imaging
    Pedram Akbari, Fatemah Nasri, Shirley X. Deng, Saima Khowaja, Seung H. Lee, William Warnica, Hua Lu, Anand Rattansingh, Mostafa Atri, Korosh Khalili and Pei York
    CJASN June 2022, 17 (6) 827-834; DOI: https://doi.org/10.2215/CJN.14931121
    Add to Selected Citations
  • Effects of Hydrochlorothiazide and Metformin on Aquaresis and Nephroprotection by a Vasopressin V2 Receptor Antagonist in ADPKD
    You have accessRestricted Access
    Effects of Hydrochlorothiazide and Metformin on Aquaresis and Nephroprotection by a Vasopressin V2 Receptor Antagonist in ADPKD
    Bart J. Kramers, Iris W. Koorevaar, Maatje D.A. van Gastel, Harry van Goor, Kenneth R. Hallows, Hiddo L. Heerspink, Hui Li, Wouter N. Leonhard, Dorien J.M. Peters, Jiedong Qiu, Daan J. Touw, Ron T. Gansevoort and Esther Meijer
    CJASN April 2022, 17 (4) 507-517; DOI: https://doi.org/10.2215/CJN.11260821
    Add to Selected Citations
  • Volume Progression and Imaging Classification of Polycystic Liver in Early Autosomal Dominant Polycystic Kidney Disease
    You have accessRestricted Access
    Volume Progression and Imaging Classification of Polycystic Liver in Early Autosomal Dominant Polycystic Kidney Disease
    Kyongtae T. Bae, Cheng Tao, Robert Feldman, Alan S.L. Yu, Vicente E. Torres, Ronald D. Perrone, Arlene B. Chapman, Godela Brosnahan, Theodore I. Steinman, William E. Braun, Michal Mrug, William M. Bennett, Peter C. Harris, Avantika Srivastava, Douglas P. Landsittel, Kaleab Z. Abebe and the CRISP and HALT PKD Consortium
    CJASN March 2022, 17 (3) 374-384; DOI: https://doi.org/10.2215/CJN.08660621
    Add to Selected Citations
  • Curcumin Therapy to Treat Vascular Dysfunction in Children and Young Adults with ADPKD
    You have accessRestricted Access
    Curcumin Therapy to Treat Vascular Dysfunction in Children and Young Adults with ADPKD
    Kristen L. Nowak, Heather Farmer-Bailey, Wei Wang, Zhiying You, Cortney Steele, Melissa A. Cadnapaphornchai, Jelena Klawitter, Nayana Patel, Diana George, Anna Jovanovich, Danielle E. Soranno, Berenice Gitomer and Michel Chonchol
    CJASN February 2022, 17 (2) 240-250; DOI: https://doi.org/10.2215/CJN.08950621
    Add to Selected Citations
  • Overweight and Obesity and Progression of ADPKD
    Open Access
    Overweight and Obesity and Progression of ADPKD
    Kristen L. Nowak, Cortney Steele, Berenice Gitomer, Wenchyi Wang, John Ouyang and Michel B. Chonchol
    CJASN June 2021, 16 (6) 908-915; DOI: https://doi.org/10.2215/CJN.16871020
    Add to Selected Citations
  • Patients with Protein-Truncating <em>PKD1</em> Mutations and Mild ADPKD
    You have accessRestricted Access
    Patients with Protein-Truncating PKD1 Mutations and Mild ADPKD
    Matthew B. Lanktree, Elsa Guiard, Pedram Akbari, Marina Pourafkari, Ioan-Andrei Iliuta, Syed Ahmed, Amirreza Haghighi, Ning He, Xuewen Song, Andrew D. Paterson, Korosh Khalili and York P.C. Pei
    CJASN March 2021, 16 (3) 374-383; DOI: https://doi.org/10.2215/CJN.11100720
    Add to Selected Citations
  • Use of the Urine-to-Plasma Urea Ratio to Predict ADPKD Progression
    You have accessRestricted Access
    Use of the Urine-to-Plasma Urea Ratio to Predict ADPKD Progression
    Judith E. Heida, Ron T. Gansevoort, A. Lianne Messchendorp, Esther Meijer, Niek F. Casteleijn, Wendy E. Boertien, Debbie Zittema and on behalf of the DIPAK Consortium
    CJASN February 2021, 16 (2) 204-212; DOI: https://doi.org/10.2215/CJN.10470620
    Add to Selected Citations
  • Multicenter Study of Long-Term Safety of Tolvaptan in Later-Stage Autosomal Dominant Polycystic Kidney Disease
    Open Access
    Multicenter Study of Long-Term Safety of Tolvaptan in Later-Stage Autosomal Dominant Polycystic Kidney Disease
    Vicente E. Torres, Arlene B. Chapman, Olivier Devuyst, Ron T. Gansevoort, Ronald D. Perrone, Jennifer Lee, Molly E. Hoke, Alvin Estilo and Olga Sergeyeva
    CJASN January 2021, 16 (1) 48-58; DOI: https://doi.org/10.2215/CJN.10250620
    Add to Selected Citations
  • Pansomatostatin Agonist Pasireotide Long-Acting Release for Patients with Autosomal Dominant Polycystic Kidney or Liver Disease with Severe Liver Involvement
    You have accessRestricted Access
    Pansomatostatin Agonist Pasireotide Long-Acting Release for Patients with Autosomal Dominant Polycystic Kidney or Liver Disease with Severe Liver Involvement
    Marie C. Hogan, Julie A. Chamberlin, Lisa E. Vaughan, Angela L. Waits, Carly Banks, Kathleen Leistikow, Troy Oftsie, Chuck Madsen, Marie Edwards, James Glockner, Walter K. Kremers, Peter C. Harris, Nicholas F. LaRusso, Vicente E. Torres and Tatyana V. Masyuk
    CJASN September 2020, 15 (9) 1267-1278; DOI: https://doi.org/10.2215/CJN.13661119
    Add to Selected Citations

Pages

  • Next
  • 1
  • 2
  • 3

Articles

  • Current Issue
  • Early Access
  • Subject Collections
  • Article Archive
  • ASN Meeting Abstracts

Information for Authors

  • Submit a Manuscript
  • Trainee of the Year
  • Author Resources
  • ASN Journal Policies
  • Reuse/Reprint Policy

About

  • CJASN
  • ASN
  • ASN Journals
  • ASN Kidney News

Journal Information

  • About CJASN
  • CJASN Email Alerts
  • CJASN Key Impact Information
  • CJASN Podcasts
  • CJASN RSS Feeds
  • Editorial Board

More Information

  • Advertise
  • ASN Podcasts
  • ASN Publications
  • Become an ASN Member
  • Feedback
  • Follow on Twitter
  • Password/Email Address Changes
  • Subscribe to ASN Journals
  • Wolters Kluwer Partnership

© 2022 American Society of Nephrology

Print ISSN - 1555-9041 Online ISSN - 1555-905X

Powered by HighWire